🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12006+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12006 recruiting trials

RecruitingNCT06988189

Unmasking Concealed Arrhythmia Syndromes

👨‍⚕️ Zachary Whinnett, PhD, Imperial College London📍 1 site📅 Started Sep 2024View details ↗
NARecruitingNCT06535646

Digital Health Technology for People With Mitochondrial Disease

👨‍⚕️ Carolyn M Sue, MBBS, PhD, FRACP, Professor and Director, Kinghorn Chair, Neurodegeneration at NeuRA and Director of Neurosciences at POWH📍 1 site📅 Started Sep 2024View details ↗
Phase 4RecruitingNCT06585241

A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations

🏥 ModernaTX, Inc.📍 6 sites📅 Started Sep 2024View details ↗
RecruitingNCT06462196

Natural History of Depression, Bipolar Disorder and Suicide Risk

👨‍⚕️ Elizabeth D Ballard, Ph.D., National Institute of Mental Health (NIMH)📍 1 site📅 Started Sep 2024View details ↗
Phase 2RecruitingNCT06252571

a Chronobiological Treatment Combining Evening Melatonin and Morning Light Therapy in Idiopathic Hypersomnia: a Prospective, Double Bind, Randomized, Placebo-controlled -Trial

🏥 University Hospital, Strasbourg, France📍 1 site📅 Started Sep 2024View details ↗
Phase 1RecruitingNCT06476808

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

👨‍⚕️ Bristol-Myers Squibb, Bristol-Myers Squibb📍 16 sites📅 Started Sep 2024View details ↗
EARLY_Phase 1RecruitingNCT06586658

Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells

👨‍⚕️ Shancheng Ren, MD,PhD, Shanghai Changzheng Hospital📍 1 site📅 Started Sep 2024View details ↗
NARecruitingNCT06649474

Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1

👨‍⚕️ Marine JARY, MD, CHU Estaing de Clermont Ferrand/FRANCE📍 1 site📅 Started Sep 2024View details ↗
NAEnrolling by InvitationNCT06864039

Quality of Life and Long-term Outcome of Adequately Treated Congenital Hypothyroidism

🏥 Federico II University📍 1 site📅 Started Sep 2024View details ↗
NARecruitingNCT06373601

SPAGO: Sirolimus Paclitaxel Angiographic Gain Objective

👨‍⚕️ Antonio AC Colombo, MD, Fondazione Evidence ONLUS📍 10 sites📅 Started Sep 2024View details ↗
NAEnrolling by InvitationNCT06560554

Evaluating the Effects of a Fermented Diet on Microbiome Diversity in Individuals With Long COVID

👨‍⚕️ Liousmila V Karnatovskaia, MD, Mayo Clinic📍 1 site📅 Started Sep 2024View details ↗
NARecruitingNCT06121219

Effect of Visual Retraining After Stroke

🏥 University of Rochester📍 1 site📅 Started Sep 2024View details ↗
Phase 1RecruitingNCT06393738

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

🏥 Arvinas Inc.📍 17 sites📅 Started Sep 2024View details ↗
RecruitingNCT07377747

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

👨‍⚕️ Angela Hong, Chris O'Brien Lifehouse📍 9 sites📅 Started Sep 2024View details ↗
NARecruitingNCT06605755

Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants

👨‍⚕️ jingxin42102209@126.com Li, Jingsu Provincial Centre of Disease Control and Prevention📍 1 site📅 Started Sep 2024View details ↗
NARecruitingNCT06803082

The Impact of Systemic Light Chain Amyloidosis on Eyes

👨‍⚕️ chang he, Zhongshan Ophthalmic Center, Sun Yat-sen University📍 1 site📅 Started Sep 2024View details ↗
Phase 1RecruitingNCT06484985

Study of AXT-1003 in Subjects With Advanced Malignant Tumors.

👨‍⚕️ Qian Gao, Axter Therapeutics (Beijing) Co., Ltd📍 5 sites📅 Started Sep 2024View details ↗
RecruitingNCT07315997

The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study

🏥 Brigham and Women's Hospital📍 1 site📅 Started Sep 2024View details ↗
Phase 2RecruitingNCT06728865

Evaluation of the Efficacy and Safety of Furmonertinib Combined with Bevacizumab As First-Line Treatment for EGFR-Positive Non-Small Cell Lung Cancer with Brain Metastases: a Single-Arm, Open-Label, Prospective Phase II Clinical Study

🏥 Li-kun Chen📍 1 site📅 Started Sep 2024View details ↗
Phase 2, PHASE3RecruitingNCT06011889

Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome

👨‍⚕️ Jakub Wroński, PhD, MD, National Institute of Geriatrics, Rheumatology and Rehabilitation📍 1 site📅 Started Sep 2024View details ↗
← PreviousPage 243 of 601Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →